Natixis Axonics, Inc. Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Axonics, Inc. stock. As of the latest transaction made, Natixis holds 48,872 shares of AXNX stock, worth $3.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

48,872

Previous 25,872 88.9%

Holding current value

$3.47 Million

Previous $1.74 Million 95.74%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$67.3 - $69.67 $1.55 Million - $1.6 Million	23,000 Added 88.9%	48,872 $3.4 Million
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $1.16 Million - $1.22 Million	17,454 Added 207.34%	25,872 $1.74 Million
Q1 2024 May 13, 2024	SELL	$56.67 - $69.36 $173,863 - $212,796	-3,068 Reduced 26.71%	8,418 $580,000
Q4 2023 Feb 13, 2024	SELL	$49.38 - $63.75 $495,380 - $639,540	-10,032 Reduced 46.62%	11,486 $714,000
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $166,348 - $213,784	-3,420 Reduced 13.71%	21,518 $1.21 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $6,718 - $8,429	-140 Reduced 0.56%	24,938 $1.26 Million
Q1 2023 May 12, 2023	BUY	$52.6 - $67.34 $839,075 - $1.07 Million	15,952 Added 174.8%	25,078 $1.37 Million
Q4 2022 Feb 24, 2023	SELL	$59.56 - $76.6 $994,652 - $1.28 Million	-16,700 Reduced 64.66%	9,126 $570,000
Q4 2022 Feb 13, 2023	SELL	$59.56 - $76.6 $1.83 Million - $2.35 Million	-30,703 Reduced 54.31%	25,826 $1.61 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $1.29 Million - $1.73 Million	-22,208 Reduced 28.21%	56,529 $4.07 Million
Q2 2022 Aug 12, 2022	BUY	$39.5 - $64.42 $1.45 Million - $2.36 Million	36,712 Added 87.36%	78,737 $4.47 Million
Q1 2022 May 13, 2022	BUY	$43.74 - $62.76 $204,834 - $293,905	4,683 Added 12.54%	42,025 $2.63 Million
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $30,506 - $44,743	-610 Reduced 1.61%	37,342 $2.09 Million
Q3 2021 Nov 12, 2021	SELL	$59.21 - $78.66 $164,426 - $218,438	-2,777 Reduced 6.82%	37,952 $2.47 Million
Q2 2021 Aug 13, 2021	SELL	$51.39 - $66.9 $34,688 - $45,157	-675 Reduced 1.63%	40,729 $2.58 Million
Q1 2021 May 14, 2021	BUY	$49.14 - $59.89 $2.03 Million - $2.48 Million	41,404 New	41,404 $2.48 Million

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account